Corona Immunitas: a nationwide program of antibody studies of SARS-CoV-2 in the Swiss populatio
- Conditions
- SARS-CoV2 infection (COVID-19)Infections and Infestations
- Registration Number
- ISRCTN18181860
- Lead Sponsor
- Swiss School of Public Health
- Brief Summary
2020 Results article in https://www.doi.org/10.1016/S0140-6736(20)31304-0 early results (added 09/07/2020) 2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33098441/ protocol (added 26/10/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35296242/ Seroprevalence and attitudes of care home and in-home care staff (added 18/03/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35725472/ Results from the Swiss national seroprevalence study Corona Immunitas (added 21/06/2022) 2023 Results article in https://doi.org/10.1016/j.clnu.2023.04.007 Association of plasma zinc levels with anti-SARS-CoV-2 IgG and IgA seropositivity in the general population: A case-control study (added 03/05/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37257891/ Recovery and symptom trajectories up to 2 years after SARS-CoV-2 infection (added 01/06/2023) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35295967/ Protocol and initial results of Corona Immunitas Digital Follow-Up eCohort (added 29/08/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37025205/ Association between serologically confirmed COVID-19 infection and cognitive functioning in community dwelling older adults (added 29/08/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36959642/ Changes in socioeconomic resources and mental health after the second COVID-19 wave (added 29/08/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35929427/ Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves (added 29/08/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35611352/ Impact of screen time and green time on mental health in children and adolescents during the COVID-19 pandemic (added 29/08/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37149211/ Longitudinal humoral and cell-mediated immune responses (added 29/08/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36631745/ Prevalence and association of frailty with SARS-CoV-2 infection in older adults (added 29/08/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36187688/ SARS-CoV-2 infection among employees working from home and on site (added 29/08/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35019254/ SARS-CoV-2 seroprevalence and COVID-19 disease among people on opioid agonist treatment (added 29/08/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36870034/ Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors (added 29/08/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35381519/ Trajectories of depression, anxiety and stress during the pandemic (added 29/08/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35418817/ Vaccination intention, beliefs, attitudes, and trust (added 29/08/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 28000
1. No acute SARS-CoV-2 infection: no presence of symptoms for at least 48 hours
2. In case of a SARS-CoV-2 infection verified by a RT-PCR test, the earliest inclusion is 21 days after the test date
1. No informed consent
2. Suspicion of acute COVID-19 infection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method